ARGX argenx SE

ARGX argenx SE

Healthcare · Biotechnology

Desk view

Watchingmedium conviction · entry $852-$870 on a settled close back above the 200-day that holds a retest, after the October 22 report (stop: settled close below $805; first target ~$928) — not entered
Basis Logged decision ·Entry target
Updated

Market read

POC $841.62 · VWAP $848.97 · -3.5% vs 12m avg buyer

pullback vol: expandingchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

Watchlists @focus@ibb

ARGX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ARGX belongs to, members best 30-day change first — ARGX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@focus

Next earnings ARGX reports in 5 days Oct 22

Against street estimates

How ARGX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 23 · projection Oct 16

Result
Jul 23 6.197.32+18.2%Beat
May 7 4.925.52+12.1%Beat
Feb 26 6.118.02+31.2%Beat
Oct 30 '25 4.165.18+24.5%Beat
Jul 31 '25 3.023.74+24.0%Beat
May 8 '25 2.312.58+11.7%Beat
Feb 27 '25 1.770.75-57.7%Miss
Oct 31 '24 0.061.39+2120.1%Beat

Recent news

Headlines about ARGX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 16

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Jul 23 Catalyst ARGX earnings
Jun 29 Deep Dive Argx Deep Dive